Biorasis, Inc.
Biorasis, Inc. (Biorasis) is a privately held medical device company. The company is principally engaged in the marketing and commercialization of implantable biosensors. Biorasis uses University of Connecticut (UCONN) spin-off technology to develop a wireless, needle-implantable, miniaturized glucose sensor for real-time, continuous glucose monitoring. The principal products of the company is GlucoWizzard, which interfaces with a variety of drug-dispensing units and provides continuous glucose monitoring to achieve closed-loop insulin delivery. The company focuses on research and development (R&D) activities to develop innovative products in the areas of Diabetes and Animal care. The company operates as a subsidiary of Optoelectronic System Consulting, Inc. Biorasis is headquartered in Connecticut, the US.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

